etoposide has been researched along with kaempferol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Bae, M; Choi, SU; Choi, SZ; Kim, CS; Kim, SY; Lee, KR; Oh, DC; Oh, J; Son, MW; Subedi, L; Suh, WS | 1 |
| Barjesteh van Waalwijk van Doorn-Khosrovani, S; Godschalk, RW; Janssen, J; Maas, LM; Nijhuis, JG; van Schooten, FJ | 1 |
| Choi, JS; Li, C; Li, X | 1 |
| Berman, C; Emmanuel, F; Goodenow, D; Richardson, C; Sahyouni, M | 1 |
| Juszczak, M; Kluska, M; Stochmal, A; Woźniak, K; Żuchowski, J | 1 |
6 other study(ies) available for etoposide and kaempferol
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Anti-Neurodegenerative Biflavonoid Glycosides from Impatiens balsamina.
Topics: Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biflavonoids; Glycosides; Humans; Impatiens; Lipopolysaccharides; Macrophages; Mice; Molecular Structure; Neuroprotective Agents; Nitric Oxide; Nuclear Magnetic Resonance, Biomolecular; Republic of Korea | 2017 |
Dietary flavonoids induce MLL translocations in primary human CD34+ cells.
Topics: Antigens, CD34; Cells, Cultured; Dietary Supplements; DNA Breaks, Double-Stranded; Etoposide; Flavonoids; Genistein; Histone-Lysine N-Methyltransferase; Humans; Kaempferols; Leukemia; Leukocytes, Mononuclear; Myeloid-Lymphoid Leukemia Protein; Quercetin; Translocation, Genetic | 2007 |
Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dietary Supplements; Drug Interactions; Etoposide; Injections, Intravenous; Intestines; Kaempferols; Liver; Male; Rats; Rats, Sprague-Dawley | 2009 |
Bioflavonoids cause DNA double-strand breaks and chromosomal translocations through topoisomerase II-dependent and -independent mechanisms.
Topics: Animals; Cell Line; Chromosome Breakpoints; Chromosomes, Mammalian; Dexrazoxane; DNA; DNA Breaks, Double-Stranded; DNA Repair; DNA Topoisomerases, Type II; Etoposide; Flavonoids; Genistein; Histones; Kaempferols; Luteolin; Mice; Mouse Embryonic Stem Cells; Quercetin; Topoisomerase II Inhibitors; Translocation, Genetic | 2020 |
Kaempferol and Its Glycoside Derivatives as Modulators of Etoposide Activity in HL-60 Cells.
Topics: Antioxidants; Apoptosis; Cell Cycle; Comet Assay; DNA; DNA Damage; Etoposide; HL-60 Cells; Humans; Kaempferols; Lens Plant; Oxidative Stress | 2021 |